Explore every episode of the podcast The Lancet Microbe in conversation with
| Title | Pub. Date | Duration | |
|---|---|---|---|
| Maria do Carmo Nunes, Sheila Klassen and Walderez Dutra on Rheumatic Heart Disease | 31 Aug 2026 | 00:30:15 | |
In this episode, we discuss the Series on Rheumatic Heart Disease published jointly by The Lancet Microbe and The Lancet Regional Health – Americas. We cover why this Series matters to the scientific community, how neglected the disease remains, its incidence across the Americas, and how it's managed in the populations most affected. We also examine the clinical and microbiological challenges in diagnosis, and what's next for vaccine development and treatment. Click here to read the full articles in the series: https://www.thelancet.com/journals/lanam/article/PIIS2667-193X(26)00194-8/fulltext https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(26)00154-0/fulltext https://www.thelancet.com/journals/lanam/article/PIIS2667-193X(26)00196-1/fulltext https://www.thelancet.com/journals/lanam/article/PIIS2667-193X(26)00195-X/fulltext And comment https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(26)00150-3/fulltext
| |||
| Luria Leslie Founou on neonatal sepsis in Africa | 12 Aug 2026 | 00:23:01 | |
Phoebe Ashley-Norman talks with Luria Leslie Founou about neonatal sepsis in Cameroon and sub-Saharan Africa more broadly, in conversation around the Lancet Microbe Personal View "Neonatal sepsis in Africa: what are we missing" Read the Personal View here: https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(26)00029-7/fulltext Dr Founou is a microbiologist and researcher with a focus on antimicrobial resistance and infectious diseases. She is also Founder and CEO of D2Africa (Dare to Dream for Africa), which can be found on YouTube at Dare to Dream for Africa - YouTube. D2Africa Stories is her podcast, where she shares the stories of inspiring African scientists and change-makers, available here D2AFRICA Stories - YouTube. | |||
| Antimicrobial resistance National Action Plans and the role of microbial genomics with with Kate Baker and Tess Johnson | 24 Jun 2026 | 00:33:53 | |
In this episode, we discuss antimicrobial resistance (AMR) priorities, as outlined in the UK National Action Plan (NAP) for AMR, and how microbial genomics can contribute to meeting them in the UK and beyond. Guests Kate Baker, a researcher at the Department of Genetics, University of Cambridge (Cambridge, UK) and Tess Johnson, a bioethicist at the Ethox Centre of the University of Oxford (Oxford, UK) explain the context in which NAPs for AMR are develped in individual countries, and specifically in the UK, following the first release of WHO's AMR Global Action Plan (GAP) in 2015 and its subsequent update adopted at the 79th World Health Assembly in 2026. They then run us through the outcomes of a stakeholder workshop of the UK Transdisciplinary Antimicrobial Resistance Genomics Network (TARGetAMR) and detail how microbial genomics can be mapped onto all the key priorities of the UK AMR NAP, and highlight key areas that need further development and who the key players in addressing these gaps should be. Finally, they expand their discussion beyond the UK, highlighting how their findings, might or might not be transferrable to other countries. In their conversation, they also mention a TARGetAMR comic, which can be found here https://www.targetamr.org.uk/our-comic/ Click here to read the full article: https://doi.org/10.1016/j.lanmic.2026.101372
| |||
| Henriette Nielsen on vaginal microbiota transplantation | 25 May 2026 | 00:16:53 | |
Elisa Pucu speaks with Henriette Svarre Nielsen about their recently published randomised controlled trial, “Vaginal microbiota transplantation for treatment of vaginal dysbiosis without the use of antibiotics: a double-blind, randomised controlled trial in women with vaginal dysbiosis.” Together, they explore the study’s key findings, its implications for women’s health, and the growing importance of vaginal microbiota transplantation as a research frontier. They also reflect on what lies ahead for this emerging field. https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(25)00222-8/fulltext | |||
| Zakiul Hassan and Tahmina Shirin on Nipah virus disease | 13 Apr 2026 | 00:37:01 | |
Phoebe Ashley-Norman talks with Zakiul Hassan and Prof Tahmina Shirin about the findings of "Interpreting the natural history and pathogenesis of Nipah virus disease through clinical data, to inform clinical trial design: a systematic review", by Zakiul Hassan and colleagues. We also discuss Nipah virus disease more broadly, talking about recent phylogenetic findings, diagnostics, therapeutics, vaccines, and ongoing challenges. Read the systematic review here: https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(25)00223-X/fulltext We also touched on some past Lancet publications, which you can explore here: https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(23)00361-0/fulltext https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(24)00262-7/fulltext https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(24)00765-5/fulltext https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(23)00707-7/fulltext https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(24)00270-2/fulltext | |||
| Claas Kirchhelle and Lloyd Czaplewski on AMR governance and financing | 05 Mar 2026 | 00:36:44 | |
Elena Dalla Vecchia talks with Claas Kirchhelle and Lloyd Czaplewski about the current antimicrobial resistance (AMR) governance (with a historical perspective on how it came to be), the 2015 WHO Global Action Plan (GAP) on AMR and the draft for the 2026 updated GAP, the role of social sciences in addressing AMR, the financing mechanisms in antibiotic research and development (including push and pull incentives with public and philantropic funding), and perspectives on the future of the fight against AMR. Click here to read the full article: https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(25)00243-5/fulltext https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(25)00216-2/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv | |||
| Magnus Unemo on Zoliflodacin treatment for gonorrhea | 05 Feb 2026 | 00:16:07 | |
Elisa Pucu from The Lancet Microbe interviews Dr. Magnus Unemo of Örebro University about the clinical implications and key findings from his research. They discuss about the the microbiological analysis and whole genome sequencing of treatment failures from the zoliflodacin phase 3 clinical trial for gonorrhea—revealing insights that could change the future of treatment and antibiotic resistance. Click here to read the full articles: https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(25)00198-3/fulltext https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)01953-1/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv | |||
| Amber Barton on mass drug administration to eradicate yaws in Papua New Guinea | 06 Jan 2026 | 00:21:34 | |
Phoebe Ashley-Norman of The Lancet Microbe speaks to Amber Barton about the neglected tropical disease, yaws. Efforts to eradicate yaws were first made in the 1950s through a WHO and UNICEF campaign that reduced yaws prevalence by 90%, but it remained endemic in some regions. Global efforts involving the mass drug administration of azithromycin continue in pursuit of the WHO 2030 yaws eradication goal. In this podcast, Amber discusses how genomic epidemiology can be used to investigate the effectiveness of yaws eradication strategies, detect sublineages of yaws at higher resolution, and improve our understanding of macrolide resistance. Click here to read the full article: https://www.thelancet.com/journals/lanmic/article/piiS2666-5247(25)00157-0/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv | |||
| Britt Koskella on bacteriophages as a signature of microbiome health | 22 Dec 2025 | 00:27:53 | |
Elena Dalla Vecchia of The Lancet Microbe speaks to Dr Britt Koskella about bacteriophages and phageome, their role in modulating the bacteriome, their potential use as signatures of microbiome health and dysbiosis, and hence, indirectly, as markers of host health and disease status. From an ecological perspective, parasites (such as bacteriophages) are key drivers of the evolution of their hosts (bacteria), and so one might expect to find diverse and rich bacteriomes in the presence of a highly diverse and thriving microbiome: Britt has been exploring this possibility and discusses it in this episode. Click here to read the full article: https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(25)00124-7/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv | |||
| Christian Malaka and Livia Patrono on the surveillance of mpox in the Central African Republic | 03 Nov 2025 | 00:33:48 | |
Rebecca Barksby of The Lancet Microbe speaks to Dr Christian Malaka and Dr Livia Patrono on mpox in the Central African Republic and how researchers are using genomic surveillance to provide insights into the epidemiology of the virus. Read the full article: https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(25)00101-6/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv | |||
| Sam Lipworth and Nicole Stoesser on genotypic and phenotypic antimicrobial resistance in Escherichia coli | 07 Oct 2025 | 00:25:46 | |
Elena Dalla Vecchia talks with Dr Sam Lipworth and Prof Nicole Stoesser about the challenges and variability in genotypic predictions of antimicrobial resistance in Escherichia coli, about which they have published two papers in The Lancet Microbe: “Exploring uncatalogued genetic variation in antimicrobial resistance gene families in Escherichia coli: an observational analysis” and “Estimating the association of antimicrobial resistance genes with minimum inhibitory concentration in Escherichia coli, an observational study”. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv | |||
| Anastasia Theodosiou on controlled human infection with Neisseria lactamica in pregnancy | 01 Apr 2025 | 00:30:06 | |
Rebecca Barksby of The Lancet Microbe speaks to Dr Anastasia Theodosiou about performing a controlled human infection study in pregnant women investigating mother-to-infant transmission of Neisseria lactamica. Read the full article: Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv | |||
| Susan Meiring, Vanessa Quan, and Nelesh Govender on bloodstream infections in neonates in South Africa | 25 Feb 2025 | 00:25:42 | |
Elena Dalla Vecchia of The Lancet Microbe speaks to Susan Meiring, Vanessa Quan, and Nelesh Govender about bloodstream infections in neonates at lower-tier South African hospitals. Read the full paper, Pathogen aetiology and risk factors for death among neonates with bloodstream infections at lower-tier South African hospitals: a cross-sectional study, at https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(24)00257-X/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv | |||
| Laurence Armand-Lefevre and Luc Samison on surveillance of antimicrobial resistant Escherichia coli in humans, chickens, and the environment in Madaga... | 05 Aug 2024 | 00:26:40 | |
Rebecca Barksby of The Lancet Microbe speaks to Professor Laurence Armand-Lefevre and Professor Luc Hervé Samison about implementing the WHO Tricycle Protocol in Madagascar for the surveillance of extended-spectrum β-lactamase producing Escherichia coli in humans, chickens, and the environment. Read the full article: https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(24)00228-1/fulltext?dgcid=buzzsprout_icw_podcast_generic_eclinm Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv | |||
| Zoe Dyson and Philip Ashton on Salmonella enterica serotypes Typhi and Paratyphi A | 09 Jul 2024 | 00:31:35 | |
Elena Dalla Vecchia of The Lancet Microbe speaks to Dr Zoe Dyson and Dr Philip Ashton about the genomic characterisation of population diversity, antimicrobial resistance profiles, and transmission patterns of Salmonella enterica serotypes Typhi and Paratyphi A in Bangladesh, Nepal, and Malawi. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv | |||
| Edwin Armitage, Saffiatou Darboe, and Lamin Jaiteh on Streptococcus pyogenes | 24 May 2024 | 00:27:29 | |
Elena Dalla Vecchia of The Lancet Microbe speaks to Edwin Armitage, Saffiatou Darboe, and Lamin Jaiteh about Streptococcus pyogenes carriage and transmission in households in The Gambia. Read the full article: https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(24)00046-6/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanmic Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv | |||
| Martin Hoenigl on climate change and fungal diseases | 27 Mar 2024 | 00:36:22 | |
Rebecca Barksby of The Lancet Microbe speaks with Professor Martin Hoenigl about the impact of climate change and natural disasters on fungal diseases. Read the full article: https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(24)00039-9/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanmic Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv | |||
| Nancy Chow on sporotrichosis | 01 Mar 2024 | 00:22:29 | |
Rebecca Barksby of The Lancet Microbe speaks to Dr Nancy Chow about sporotrichosis and discusses a genomic epidemiology study of this zoonotic fungal disease among people and cats in Brazil. Read the full article: https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(23)00364-6/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanmic Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv | |||
| Deborah Williamson and Michael Moso on detecting on-SARS-CoV-2 viruses from COVID-19 rapid antigen test devices | 12 Feb 2024 | 00:20:05 | |
Elena Dalla Vecchia of The Lancet Microbe speaks to Deborah Williamson and Michael Moso about non-SARS-CoV-2 respiratory viral detection from COVID-19 rapid antigen test devices. Read the full article: https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(23)00375-0/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanmic Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv | |||
| Kate Baker on harnessing genomics for antimicrobial resistance surveillance | 23 Nov 2023 | 00:20:22 | |
Rebecca Barksby of The Lancet Microbe speaks to Professor Kate Baker about the challenges, potential, and recommendations for using genomics to monitor antimicrobial resistance. Read the full Series: https://www.thelancet.com/series/amr-genomics?dgcid=buzzsprout_icw_podcast_generic_lanmic Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv | |||
| Erica Furhmeister on monitoring antimicrobial resistance using faecal metagenomes | 02 Aug 2023 | 00:19:48 | |
Rebecca Barksby of The Lancet Microbe talks to Dr Erica Furhmeister about monitoring antimicrobial resistance using faecal metagenomes. Read the full article: https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(23)00137-4/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanmic Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv | |||
| Jie Zhou and Anika Singanayagam on their SARS-CoV-2 human challenge study | 09 Jun 2023 | 00:20:53 | |
Elena Dalla Vecchia of The Lancet Microbe speaks to Dr Jie Zhou and Dr Anika Singanayagam about their SARS-CoV-2 human challenge study. Read the full article: https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(23)00101-5/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanmic Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv | |||
| Hanna Ehrlich on antimalarial drug resistance surveillance | 31 May 2023 | 00:32:20 | |
Elena Dalla Vecchia of The Lancet Microbe speaks to Dr Hanna Ehrlich about antimalarial drug resistance surveillance and her recent cross-sectional study using xenomonitoring in Burkina Faso. Read the full article: https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(23)00063-0/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanmic Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv | |||
| Fabrice Somé sur la surveillance de la résistance aux médicaments antipaludiques (en français) | 31 May 2023 | 00:32:17 | |
Elena Dalla Vecchia du The Lancet Microbe converse avec Dr Fabrice Somé sur la surveillance de la résistance aux médicaments antipaludique et son étude récent qui a utilisé la xenosurveillance en Burkina Faso. Pour lire l’article: https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(23)00063-0/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanmic Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv | |||
| Nichola Calvani on gender equity in science | 08 Mar 2023 | 00:22:14 | |
Rebecca Barksby of The Lancet Microbe talks to Dr Nichola Calvani about gender equity in science and Herminthology, an online initiative that produces online profiles of women working in parasitology. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv | |||
| Michael Otto on using probiotics to reduce Staphylococcus aureus | 13 Jan 2023 | 00:20:42 | |
Rebecca Barksby of The Lancet Microbe talks to Dr Michael Otto and his and his collaborators’ placebo-controlled phase 2 trial that used the probiotic Bacillus subtilis to reduce Staphylococcus aureus in adults who were colonised by the bacteria in the Songkhla region of Thailand. Read the full article: Probiotic for pathogen-specific Staphylococcus aureus decolonisation in Thailand Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv | |||
| David Cameron on phage therapy | 01 Dec 2022 | 00:09:35 | |
Elena Dalla Vecchia of The Lancet Microbe speaks to Dr David Cameron about phage therapy and his and his colleagues’ recent systematic review and meta-analysis of the efficacy of phage therapy in preclinical models of bacterial infection. Read the full article: Efficacy of phage therapy in preclinical models of bacterial infection: a systematic review and meta-analysis Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv | |||
| Samuel Lipworth on Mycobacterium abscessus | 28 Sep 2021 | 00:13:23 | |
Jonathan Blott talks to Dr Samuel Lipworth about his and his collaborators' investigation of the epidemiology of Mycobacterium abscessus in England and the risk of person-to-person transmission in health-care settings Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv | |||
| Adrian Martineau on Mycobacterium tuberculosis in Ethiopia | 02 Jun 2021 | 00:14:10 | |
Rachel Hellier talks to Prof Adrian Martineau about his and his collaborators’ study that identified Mycobacterium tuberculosis complex DNA in CD34-positive peripheral blood mononuclear cells of asymptomatic individuals in Ethiopia, a setting with a high tuberculosis burden. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv | |||